bamlanivimab and etesevimab

· Lilly

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for bamlanivimab and etesevimab, covering 2021-03-05 to 2021-11-02. Get the full timeline:

Most recent: EMA ends rolling review of the antibodies bamlanivimab and etesevimab for COVID-19 following withdrawal by Lilly